T. Rowe Price Associates’s HilleVax HLVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,063
| Closed | -$15K | – | 3093 |
|
|
2025
Q1 | $15K | Hold |
10,063
| – | – | ﹤0.01% | 3015 |
|
|
2024
Q4 | $21K | Hold |
10,063
| – | – | ﹤0.01% | 2981 |
|
|
2024
Q3 | $18K | Hold |
10,063
| – | – | ﹤0.01% | 2993 |
|
|
2024
Q2 | $146K | Buy |
+10,063
| New | +$146K | ﹤0.01% | 2670 |
|
|
2022
Q3 | – | Sell |
-1,101,237
| Closed | -$12M | – | 2986 |
|
|
2022
Q2 | $12M | Buy |
+1,101,237
| New | +$12M | ﹤0.01% | 1288 |
|